TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion–positive intrahepatic cholangiocarcinoma. Goyal, L., Shi, L., Liu, L. Y, Fece de la Cruz, F., Lennerz, J. K, Raghavan, S., Leschiner, I., Elagina, L., Siravegna, G., Ng, R. W., & others Cancer discovery, 9(8):1064–1079, American Association for Cancer Research, 2019.
bibtex   
@article{goyal2019tas,
  title={TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion--positive intrahepatic cholangiocarcinoma},
  author={Goyal, Lipika and Shi, Lei and Liu, Leah Y and Fece de la Cruz, Ferran and Lennerz, Jochen K and Raghavan, Srivatsan and Leschiner, Ignaty and Elagina, Liudmila and Siravegna, Giulia and Ng, Raymond WS and others},
  journal={Cancer discovery},
  volume={9},
  number={8},
  pages={1064--1079},
  year={2019},
  publisher={American Association for Cancer Research}
}

Downloads: 0